Palio 2026 is made and published by PSTM SRL. AppBrain is an independent app data site and isn't affiliated with PSTM SRL. The app name, icon, screenshots and description belong to PSTM SRL and are shown as published on the App Store.
AppBrain's verdict
- Last updated
- September 26, 2026
Rankings
App Store top chartsApp Store Rankings for Palio 2026
Competitors
Similar apps and more from PSTM SRLMore from PSTM SRL
Releases
Updates seen on the App Store- Version
- 9.0
- Launched
- May 2024
No changelog data
User feedback
Ratings and reviews on the App StoreComments on Palio 2026 for iOS
We don't have enough comments to show example comments. Please check back later.
Technology
Found in the app by AppBrain- Price
- Free
- App size
- 81.9 MB
- Content rating
- Everyone
Technologies used by Palio 2026
About the app and developer
About Palio 2026
Palio 2026 is a productivity app developed by PSTM SRL.
User Ratings
The app has no ratings yet.
App Information
Palio 2026 is freely available from the App Store. The app size is 81.89 MB. The latest version available is 9.0. The last update was on September 26, 2026.
Technical Requirements
The app has a content rating of Everyone. The app has been available on the App Store since May 2024.
Developer information for PSTM SRL
Address:
Store listing
By PSTM SRL, from the App StoreDescription by PSTM SRL Written by the developer, not by AppBrain. Click to read.
October 14-16, 2026 – Siena, Italy
Vaccines: Healthy aging beyond infectious disease prevention
As populations age, preserving health and quality of life in later years has become a major public health priority. A key challenge is immune aging: the progressive decline and remodelling of immune function that not only increases susceptibility to infections, but also contributes to chronic inflammation, reduced resilience, frailty, and a higher risk of non-communicable diseases.
The Palio Meeting 2026 will explore the role of vaccines beyond the prevention of specific infectious diseases, focusing on their potential contribution to immune resilience and healthy longevity. The meeting will investigate how vaccination may indirectly influence biological aging by reducing infection-driven inflammation and tissue damage and by supporting immune function throughout life.
Bringing together scientists, clinicians, health economists, policymakers, and regulatory experts, the meeting will address the translational, economic, policy, and regulatory implications of this broader perspective. Its objective is to identify actionable strategies to measure, recognise, and communicate the wider value of vaccination, improve vaccine uptake among older adults, and position vaccines as a key intervention for promoting healthier and more resilient aging